Artemis Medicare Services has delivered robust financial performance in Q3FY26, with consolidated revenue rising 17.2% year-on-year to ₹2.72B from ₹2.32B in the corresponding period last year. The healthcare services company reported consolidated net profit of ₹223M, marking a 7.9% increase from ₹206M in Q3FY25.

Q3FY26 Financial Performance

The company's quarterly results demonstrate strong operational performance across key financial metrics, with notable revenue growth and margin expansion:

The revenue growth reflects the company's expanding healthcare services operations and improved market positioning. Standalone operations showed particularly strong performance with revenue growing 17.73% to ₹2.67B.

Board Meeting Outcomes

The financial results were approved during the board meeting held on February 2, 2026. The board addressed the company's Q3FY26 unaudited financial results for both standalone and consolidated operations for the quarter and nine months period ended December 31, 2025.

Fund Raising Initiatives

The board approved a comprehensive fund raising plan worth up to ₹700 crores through various financial instruments:

The fund raising initiatives will require necessary regulatory approvals and member consent as per applicable provisions of the Companies Act, 2013, and SEBI regulations.

Earnings Conference Call

Following the results announcement, Artemis Medicare Services conducted an earnings conference call on February 3, 2026, to discuss the operational and financial performance for Q3 and 9M FY26. The company has made the audio recording of this conference call available on its website for stakeholders and investors.

Exceptional Items Impact

The company reported exceptional items of ₹30.74M related to the impact of new Labour Codes notified by the Government of India in November 2025. These codes consolidate twenty-nine existing labour laws and resulted in increased gratuity and leave liability, presented as a non-recurring exceptional item.

Trading Window Status

The trading window restrictions that were implemented from January 1, 2026, concluded following the results declaration. The window remained closed until 48 hours after the financial results announcement, in compliance with regulatory requirements.

Artemis Medicare Services Limited has completed the allotment of equity shares under its employee stock option scheme, marking another step in its capital structure evolution. The healthcare company announced the allotment of shares to grantees who exercised their vested options under the established stock option plan.

Share Allotment Details

The company has allotted 1,05,750 equity shares under its Management Stock Option Plan-2021. These shares have been issued as fully paid-up equity shares with a face value of ₹1 each.

Impact on Share Capital

The allotment has resulted in an increase in the company's issued and paid-up equity share capital. The capital structure change reflects the exercise of vested options by eligible grantees under the stock option plan.

Share Characteristics

The newly allotted equity shares carry identical rights and privileges as existing equity shares of the company. They will rank pari-passu with the existing equity shares of the company.

Regulatory Compliance

The company has fulfilled its disclosure obligations regarding the allotment of shares under its employee stock option scheme. This action aligns with Artemis Medicare Services' commitment to employee participation in equity ownership while maintaining compliance with regulatory frameworks governing employee stock option schemes in the healthcare sector.